Creating a platform to test the safety and effectiveness of sunscreen ingredients.
Development of the UValidate platform for the profiling of topically applied chemical agents.
This study is testing a new way to check how safe and effective sunscreen ingredients are for your skin when they're exposed to sunlight, so we can create better sunscreens that protect you from skin damage and lower the risk of skin cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Amelia Technologies, LLC NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10707098 on NIH RePORTER |
What this research studies
This research focuses on developing a new platform called UValidate to evaluate the safety and effectiveness of chemical agents used in sunscreens. It aims to assess how these agents interact with skin cells when exposed to UV radiation, which can cause skin damage and increase the risk of skin cancer. By using a high-throughput screening method, the research will test combinations of sunscreen ingredients in a controlled environment, ensuring that the approach is both efficient and ethical. The goal is to provide better formulations that protect against skin damage while minimizing health risks.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals concerned about skin health, particularly those who frequently use sunscreen or are at risk for skin disorders.
Not a fit: Patients who do not use sunscreen or have no interest in skin health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective sunscreen products that better protect patients from skin damage and cancer.
How similar studies have performed: Previous research has shown promise in developing high-throughput screening methods for testing chemical agents, indicating that this approach could yield valuable insights.
Where this research is happening
Washington, United States
- Amelia Technologies, LLC — Washington, United States (Active)
Researchers
- Principal investigator: Sykora, Peter — Amelia Technologies, LLC
- Study coordinator: Sykora, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.